1. Issue Highlights Clinical Gastroenterology and Hepatology
Charles Kahi 
Clinical Gastroenterology and Hepatology 
Volume 14, Issue 11, Pages (November 2016)
DOI: /j.cgh
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
Subgroup analysis: sensitivity of second- vs first-generation systems for polyps ≥6 mm (A) and ≥10 mm (B). Events, TPs ([true positives], ie, patients with polyps ≥6 mm [A] or ≥10 mm [B]) found at CCE; Total, TPs at the reference standard (colonoscopy). Proportion, percentage of TPs found at CCE among patients with endoscopically proven polyps ≥6 mm (A) or ≥10 mm (B).
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Receiver operator characteristic curves for our scoring system for severe LGIB in derivation and validation cohorts.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

4. Figure 3
Outcome measures at week 14 for vedolizumab therapy in patients with (A) Crohn’s disease and (B) ulcerative colitis. *P value less than .005 when comparing week 6 and week 14 efficacy results.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions